Objective: The aim of our study was to investigate whether platelet indices were affected in patients with Hashimoto's thyroiditis (HT). Method: 11 patients (10 female, 1 male) with HT and 26 subjects with nodular goiters (19 female, 7 male) selected as control group were included in the study. All cases were examined for complete blood count parameters (leukocyte count, neutrophil count and percentage, lymphocyte count and percentage, platelet count, plateletcrit, platelet distribution width (PDW), and mean platelet volume (MPV)). Results: Leukocyte count, neutrophil count and percentage, lymphocyte percentage, platelet count, plateletcrit, and MPV in the patient group were not statistically different from the control group. Lymphocyte count and PDW were significantly higher in patients with HT than in the control group. Conclusion: Our results suggest that patients with HT have higher PDW levels. Increased PDW in HT may be helpful in diagnosis, floow-up, and prognosis of the disease.
INTRODUCTION
Hashimoto's thyroiditis (HT), part of the spectrum of autoimmune thyroid diseases, is the most common form of inflammatory thyroid disorders and the most common cause of hypothyroidism 1, 2 . An increase in the incidence of HT has attracted attention in recent years 3 . It is known that a number of genetic and environmental factors are responsible for the development of HT, while there are still many unexplained points in the etiopathogenesis 4 . Many studies showed that both cellular and humoral immunity are important in HT 5, 6 . Activation of follicular helper T cells and disturbance of T regulatory cells may play a role in initiation/perpetuation of the disease 3 . There is a growing interest about the effects of platelets on immunological and inflammatory processes [7] [8] [9] [10] . There is a limited number of studies in the literature on the relationship between HT and platelet indices [11] [12] [13] . Inflammatory condition in HT can affect the number, the size, and the distribution of blood platelets 7, [11] [12] [13] . The aim of our study was to investigate whether platelet indices were affected in patients with pathologically diagnosed HT.
METHODS
This study started with the approval of the Ethics Committee of the Faculty of Medicine of our University (31.05.2017/101). Between 01.03.2014 and 28.02.2017, 11 patients (10 female, 1 male) with HT diagnosis in the pathology clinic of our University Research and Practice Center Hospital and 26 cases of nodular goiters (19 female, 7 male) selected as control group were included in the study. The aim of that we selected the patients with nodular goiter as control group was to ensure that they didn't have pathologically HT. Exclusion criteria were as follows: a chronic disease such as asthma, chronic obstructive pulmonary disease, and hypertension and/or concomitant thyroid carcinoma.
All patients who were included in the study were examined for complete blood count parameters (leukocyte count, neutrophil count and percentage, lymphocyte count and percentage, platelet count, plateletcrit, platelet distribution width (PDW), and mean platelet volume (MPV)). These parameters were measured by a hematology analyzer (ABX Pentra DX 120, HORIBA, France).
Statistical Analyses
The Kolmogorov-Smirnov test was used to determine whether the variables were distributed normally. Fisher's exact test was used to determine whether there is a gender difference between the groups and Mann-Whitney U test to determine whether there is a difference in terms of age, leukocyte count, neutrophil count and percentage, lymphocyte count and percentage, platelet count, plateletcrit, PDW, and MPV. A p value less than 0.05 was considered statistically significant.
RESULTS
There was no significant difference between the groups in terms of age and gender (Table  1) . Leukocyte count, neutrophil count and percentage, lymphocyte percentage, platelet count, plateletcrit, and MPV in the patient group were not statistically different from the control group (Table 1) . Lymphocyte count and PDW were significantly higher in patients with HT than in the control group (Figures 1, 2, and  3) .
DISCUSSION
HT is an autoimmune disease characterized by the infiltration of the thyroid gland by both B and T lymphocytes. For this reason, there is a role for both cellular and humoral immunity in its pathogenesis 3 . We found that lymphocytes count in peripheral blood of patients with HT was significantly higher than in the control group (Figure 1 ). Lymphocytosis is a nonspecific finding that is common during the healing period of many acute infectious diseases. It is known that HT is one of noninfectious diseases associated with lymphocytosis 14 . Our study showed that the PDW values, a specific marker of platelet activation, were significantly increased in HT. Sit et all. 11 and Aktas et all. 15 found that PDW values in patients with HT did not differ from those in healthy controls. Atile et all. 16 raported that PDW values of patients with hypothyroid HT were similar to those of both healthy controls and patients with treated euthyroid HT. However, Bilge et all. 17 found that PDW values were significantly increased in euthyroid women with HT compared with healthy controls. The findings of our study agree with those of Bilge et all. Zhu et all. 18 have determined elevated follicular helper T cells in the peripheral blood of patients with HT. It has been shown that follicular helper T cells produce high levels of IL-21 that is associated with the development of autoimmune diseases 19, 20 . Cytokines such as IL-1β, IL-6, and IL-21 can play a role in the pathogenesis of HT [20] [21] [22] and also can enhance thrombopoiesis 24 . Accelerated thrombocytes generation leads to presence of large thrombocytes 25 , hence, to increased PDW.
We found that platelet count was not different in patients with HT compared with that of control group. This result agreed with previous studies 11, 12 . During inflammatory process, there is a rapid recruitment of thrombocytes to the field of inflammation where they are consumed due to their destruction 26 . For this reason we consider that in patients with HT, platelet production increases, but, on the other hand, platelet consumption also enhances and thus platelet count remains unchanged (Figure 4 ). In conclusion, our results suggest that patients with HT have higher PDW levels. Increased PDW in HT may be helpful in diagnosis, followup, and prognosis of the disease and for better understanding of mechanisms associated with the disease pathogenesis. However, further studies are need to confirm its validity in patients with HT.
